Back to CITADEL ADVISORS LLC CITADEL ADVISORS LLC

APLSAPLS
Showing 8 of 31 quarters

Position history for CITADEL ADVISORS LLCCITADEL ADVISORS LLC's holdings in APELLIS PHARMACEUTICALS INC

CITADEL ADVISORS LLC previously held 0 shares of APLS (APELLIS PHARMACEUTICALS INC), worth $0 as of 2026-Q2.

Final Value

$0

Final Shares

0

Total Value Change

-$5.7M

Total Shares Change

-198,133

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Exited
0
-100.0%
$00.0%$41.03
0
2026-Q1
Decreased
38,887
-94.0%
$1.6M0.0%$20.16
0
2025-Q4
Increased
648,229
+10.5%
$16.3M0.0%$25.24
31
2025-Q3
Increased
586,452
+32.5%
$13.3M0.0%$22.65
36
2025-Q2
Increased
442,560
+97.5%
$7.7M0.0%$17.43
44
2025-Q1
Increased
224,096
+99.3%
$4.9M0.0%$24.27
43
2024-Q4
Decreased
112,423
-43.3%
$3.6M0.0%$31.90
0
2024-Q3
Increased
198,133
+28.8%
$5.7M0.0%$29.47
34

Other major holders of APLS: Avoro Capital Advisors LLC, WELLINGTON MANAGEMENT GROUP LLP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used